Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00031408 · ClinicalTrials.gov registry record

Consent for Use of Stored Patient Specimens for Future Testing

A clinical trial of HIV Infections, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Active
Registry status
17,444
Enrollment target
20
Study locations

NCT00031408 is a study of HIV Infections that is active but no longer recruiting, run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. The registered enrollment target is 17,444 participants, above the 414-participant average among 542 other HIV Infections trials with a reported enrollment target (4114% higher). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00031408, a study of HIV Infections, is active but no longer recruiting, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

ACTIVE NOT RECRUITING
Registry status
17,444 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.

Conditions Studied

HIV Infections

Study Locations (20)

California

  • Univ of Southern California / LA County USC Med Ctr - Los Angeles
  • Charles Drew Medical Center - Los Angeles
  • UCLA CARE Ctr - Los Angeles
  • Univ of California, San Diego - San Diego
  • Univ of California San Francisco - San Francisco
  • San Mateo AIDS Program / Stanford Univ - Stanford
  • Stanford Univ Med Ctr - Stanford
  • Willow Clinic / Stanford Univ - Stanford
  • Harbor General/UCLA - Torrance

Illinois

  • Northwestern Univ Med School - Chicago
  • Rush Presbyterian - Saint Luke's Med Ctr - Chicago
  • The CORE Ctr - Chicago

Indiana

  • Indiana Univ Hosp - Indianapolis
  • Methodist Hosp of Indiana / Life Care Clinic - Indianapolis
  • Wishard Hosp - Indianapolis

Colorado

  • Univ of Colorado Health Sciences Ctr - Denver

District of Columbia

  • Georgetown Univ Med Ctr - Washington D.C.

Florida

  • Univ of Miami School of Medicine - Miami

Georgia

  • Emory Univ - Atlanta

Iowa

  • Department of Internal Medicine, University of Iowa Hospitals & Clinics CRS (1504) - Iowa City

Trial Details

FieldValue
Enrollment Target 17,444 participants
Start Date 2002-02-13
Est. Completion 2027-12-31

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

45 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00031408

The ClinicalTrials.gov registry entry for NCT00031408 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 17,444 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 414-participant average among 542 other HIV Infections trials with a reported enrollment target (4114% higher). The listed sponsor is Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00031408 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Illinois, Indiana.

Frequently Asked Questions

What is clinical trial NCT00031408 about?

NCT00031408 is a clinical study titled "Consent for Use of Stored Patient Specimens for Future Testing". The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.

What is the current status of trial NCT00031408?

This trial is currently active not recruiting. The enrollment target is 17,444 participants. The study started on 2002-02-13. Estimated completion is 2027-12-31.

What conditions does trial NCT00031408 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT00031408?

This trial is sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00031408 being conducted?

This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.